SYNTHESIS AND EVALUATION OF ANTIBACTERIAL, ANTIFUNGAL, CYTOTOXIC ACTIVITIES OF SOME ASYMMETRIC 2-METHYLIMIDAZOLE-4,5-DICARBOXAMIDE DERIVATIVES

Nguyen Hoai Phuong Huynh1,, Viet Hoang Do1, Phuong Truong1, Võ Thị Cẩm Vân1
1 University of Medicine and Pharmacy at Ho Chi Minh City

Main Article Content

Abstract

Background: Imidazole is a heterocyclic structure that has been received much attention in pharmaceutical chemistry and has been appeared in many compounds with antibacterial, antifungal, antiviral, anticancer, analgesic, and anti-inflammatory activities. We chose to study 2-methylimidazole-4,5-dicarboxamide and evaluate the antibacterial, antifungal, cytotoxic activities of those derivatives. Objectives: Synthesis of asymmetric 2-methylimidazole-4,5-dicarboxamides and screening the antibacterial, antifungal, cytotoxic activitives of these derivatives. Materials and methods: The asymmetric 2-methylimidazole-4,5-dicarboxamides were synthsized from 2-methylbenzimidazole through 2 steps: Sythesis of imidazole dicarboxylic acid and synthesis of diamid. The structures of all synthethic compounds were confirmed by melting point, IR spectrum, MS spectrum, 1H-NMR spectrum. The antibacterial, antifungal activity was screened using well diffusion method on agar. The cytotoxic activity was screening using MTT method. Results: Four asymmetric 2-methylimidazole-4,5-dicarboxamides were synthesized with medium yields (25-37% for the last step). These compounds showed no antibacterial and antifungal activities on tested species. They also showed no cytotoxic activity. Conclusion: Four asymmetric 2-methylimidazole-4,5-dicarboxamides have no antibacterial and antifungal activities on tested species and no cytotoxic activities on tested cell lines.

Article Details

References

1. Shalini K., Sharma P., and Kumar N. Imidazole and its biological activities: review. Der. Chem. Sin. 2010. 1(3), 36-47.
2. Shingalapur R. V., Hosamani K. M., and Keri R. S. Synthesis and evaluation of in vitro anti-microbial and anti-tubercular activity of 2-styryl benzimidazoles. European journal of medicinal chemistry. 2009. 44(10), 4244-4248, doi: 10.1016/j.ejmech.2009.05.021
3. Sharma D., Narasimhan B., Kumar P., et al. Synthesis, antimicrobial and antiviral evaluation of substituted imidazole derivatives. Eur J Med Chem. 2009. 44(6), 2347-53, https://doi.org/10.1016/j.ejmech.2008.08.010
4. Tonelli M., Simone M., Tasso B., et al. Antiviral activity of benzimidazole derivatives. II. Antiviral activity of 2-phenylbenzimidazole derivatives. Bioorganic & medicinal chemistry. 2010. 18(8), 2937-2953, doi: 10.1016/j.bmc.2010.02.037
5. Puratchikody A. and Doble M. Antinociceptive and antiinflammatory activities and QSAR studies on 2-substituted-4,5-diphenyl-1H-imidazoles. Bioorganic & Medicinal Chemistry. 2007. 15(2), 1083-1090, doi: 10.1016/j.bmc.2006.10.025
6. Achar K. C. S., Hosamani K. M., and Seetharamareddy H. R. In-vivo analgesic and anti-inflammatory activities of newly synthesized benzimidazole derivatives. European journal of medicinal chemistry. 2010. 45(5), 2048-2054, https://doi.org/10.1016/j.ejmech.2010.01.029
7. Ozkay Y., Işikdağ I., Incesu Z., et al. Synthesis of 2-substituted-N-[4-(1-methyl-4,5-diphenyl-1H-imidazole-2-yl)phenyl]acetamide derivatives and evaluation of their anticancer activity. European journal of medicinal chemistry. 2010. 45(8), 3320-3328, https://doi.org/10.1016/j.ejmech.2010.04.015
8. Refaat H. M. Synthesis and anticancer activity of some novel 2-substituted benzimidazole derivatives. European journal of medicinal chemistry. 2010. 45(7), 2949-2956. Doi: 10.1016/j.ejmech.2010.03.022
9. Hadizadeh F., Hosseinzadeh H., Motamed-Shariaty V. S., et al. Synthesis and Antidepressant Activity of N-Substituted Imidazole-5-Carboxamides in Forced Swimming Test Model. Iranian Journal of Pharmaceutical Research. 2010. 7(1), 29-33.
10. Baures P. W., Heterocyclics HIV-1 protease inhibitors. Organic Letters. 1999. 1(2), 249-252, https://doi.org/10.1021/ol990586y
11. VanCompernolle S. E., Wiznycia A. V., Rush J. R, et al. Small molecule inhibition of hepatitis C virus E2 binding to CD81. Virology. 2004. 314(1), 371-380, doi: 10.1016/s0042-6822(03)00406-9
12. Saudi M., Zmurko J., Kaptein S., et al. Synthesis and evaluation of imidazole-4,5-and pyrazine-2,3-dicarboxamide targeting dengue and yellow fever virus. European Journal of Medicinal Chemistry. 2014. 87. 529-539, doi: 10.1016/j.ejmech.2014.09.062
13. Gunness P., Aleksa K., Kosuge K., et al, Comparison of the novel HK-2 human renal proximal tubular cell line with the standard LLC-PK1 in studying drug-induced nephrotoxicity. Can J Physiol Pharmacol. 2010. 88(4), 448-455, doi:10.1139/y10-023.
14. Howe R., Andrews J. BSAC standardized disc susceptibility testing method (version 11), Journal of antimicrobial chemotherapy. 2012. 67(12), 2783-2784, https://doi.org/10.1093/jac/dks391
15. Meerloo J., Kaspers G. J., Cloos J, Cell Sénitivity Assays: The MTT Assay. Cancer Cell Culture. 2011, 237-245.